BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

BOEHRINGER INGELHEIM PHARMECEUTICAL — Receipts Report

LD-2 disclosure · Registration

BOEHRINGER INGELHEIM PHARMECEUTICAL

via MOFFETT GROUP, LLC

1st Quarter (Jan 1 - Mar 31) · 2008Posted Jan 21, 2009Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: BOEHRINGER INGELHEIM PHARMECEUTICAL
Description: Pharmaceutical Company
Location: Connecticut · United States of America

Registrant

Firm: MOFFETT GROUP, LLC
Description: Lobbying
Location: Washington, District of Columbia, United States of America

Lobbying activities

2 issues

Taxation/Internal Revenue Code
Pharmaceutical issues and issues related to tariff suspension
LobbyistsANTHONY J MOFFETT
Pharmacy
Pharmaceutical issues and issues related to tariff suspension
LobbyistsANTHONY J MOFFETT

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.